Skyscape Web Viewer : TNM Cancer Staging Manual : Main Index

View All
Clinical criteria to categorize a lesion as a separate tumor nodule (intrapulmonary metastasis)
Clinical criteria to categorize a tumor as multifocal GG/L adenocarcinoma
Clinical criteria to categorize a tumor as pneumonic-type adenocarcinoma
Clinical criteria to distinguish second primary versus related tumors
Clinical features of functional pancreatic neuroendocrine tumors
Clinical features of unusual histologies and their implications for staging
Clinical Laboratory Improvement Amendments (CLIA) Neuroendocrine Tumors of the Appendix Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Duodenum and Ampulla of Vater Neuroendocrine Tumors of the Jejunum and Ileum Neuroendocrine Tumors of the Stomach
Clinical mapping system for conjunctival carcinoma
Clinical mapping system for conjunctival melanoma
Clinical N2 is defined as palpable mobile or bilateral lymph nodes
Clinical N3 is defined as palpable fixed inguinal nodal mass or pelvic lymphadenopathy unilateral or bilateral
Clinical stage (cTNM) and overall survival in patients diagnosed with gastric cancer, stratified by clinical stage groupings, based on NCDB data (2004-2008; median follow-up, 12 months; n = 7,306)
Clinical stage and 1-, 3-, and 5-year and median overall survivals in patients diagnosed with gastric cancer, stratified by clinical stage groupings, based on NCDB data
Clinical stage and 1-, 3-, and 5-year and median overall survivals in patients with gastric cancer who received curative or palliative surgery, stratified by clinical stage groupings, based on Shizuoka Cancer Center data
Clinical stage and overall survival in patients with gastric cancer who received curative or palliative surgery, stratified by clinical stage groupings, based on Shizuoka Cancer Center data (2002-2015; median follow-up, 47 months; n = 4,091)
CLL
CML
Codification of tumor staging into the TNM system
College of American Pathology (CAP) Introduction and Overview Neuroendocrine Tumors of the Colon and Rectum Neuroendocrine Tumors of the Jejunum and Ileum Neuroendocrine Tumors of the Stomach
Colon and rectal carcinoma
Colony-stimulating factor Other Plasma Cell Disorders Plasma Cell Myeloma
Colorectal NET observed Kaplan-Meier 3-year survival, 95% CIsby clinical and pathological (Path) stage, diagnosis years 2010 to 2013, age greater than or equal to 18, no prior cancers
Combination therapy, for benign prostatic hyperplasia (BPH)
Combined hormonal contraceptive patch
Combined hormonal vaginal ring
Combined oral contraceptive
Combined therapy, for depression
Common cold, management of
Common iliac lymph nodes cervix uteri Corpus Uteri: Carcinoma and Carcinosarcoma fallopian tube ovary Vagina
Common variable immune deficiency (CVID)

NDX